GMO Benchmark-Free Allocation Fund Class IV GBMBX

Morningstar Medalist Rating
  • NAV / 1-Day Return$34.48  /  +0.09%
  • Fund Size$2.7B
  • Adjusted Expense Ratio0.800%
  • Net Expense Ratio0.620%
  • Fee Level: DistributionAverage
  • Share Class TypeInstitutional
  • Morningstar CategoryGlobal Moderate Allocation
  • Equity Style Box (Funds)Large Value
  • Fixed-Income Style Box (Funds)—
  • Investment StatusOpen
  • TTM Yield3.75%
  • Turnover Ratio11%

Morningstar’s Analysis GBMBX

Will GBMBX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

A consistent, if unconstrained, execution of valuation-driven investing.

Analyst Vedran Beogradlija

Vedran Beogradlija

Analyst

Summary

GMO Benchmark-Free Allocation stands apart from peers as a pure expression of the firm’s valuation-focused investment philosophy. An expert duo backed by robust resources shepherds the strategy, but the unconstrained approach can face unique challenges.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GBMBX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings17.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Us 2yr Note (Cbt)

17.09461M
Government

Us 5yr Note (Cbt)

17.09461M
Government

United States Treasury Notes 4.19%

9.98269M
Government

United States Treasury Notes 4.14%

8.39226M
Government

10 Year Treasury Note Future Dec 26

6.05163M
Government

Ultra 10 Year US Treasury Note Future Dec 26

4.47121M
Government

United States Treasury Notes 1.88%

3.1785M
Government

Contra Derivatives - Options

−2.95−80M
—

Contra Derivatives - Swaps

−3.87−104M
—

Contra Derivatives - Futures

−42.00−1B
—

Sponsor Center